Neuralink Show And Tell Event Delayed 30 Days
Neuralinks “show and tell” event, which was to be held October 31st, has been pushed back a month to November 30th according to a new tweet by company founder Elon…
Moderna Sues Pfizer And Biontech Over mRNA Vaccine Patent Infringement
Moderna has announced it is suing Pfizer and BIontech, alleging the Pfizer vaccine infringed on three patents owned by Moderna related to mRNA vaccine technology. The company has filed two…
As Government Closes Pandemic Funds, Insurers To Pay More For Vaccines
As the Covid-19 pandemic relief fund is set to run out, the Biden administration is preparing to shift the burden for payment for Covid vaccines to consumers and health insurers,…
Pfizer And Moderna Choose Different Uses For Their Covid Windfalls
After enjoying windfall profits from the Covid pandemic and associated global mass-vaccination pushes, Pfizer and Moderna are pursuing different business strategies going forward. Pfizer has chosen to push its vaccine…
Monkeypox Treatment Maker SIGA Technologies Flooded With Orders
Tecovirimat, brand name TPOXX is currently the only available treatment for monkeypox. While it has only been tested for use against smallpox, its manufacturer SIGA Technologies (SIGA) is now flooded…
FDA Calls For Fall Boosters To Target BA.4/BA.5 Covid Strains
The US FDA has requested that COVID-19 vaccine manufacturers custom tailor their fall booster vaccines for the BA.4/BA.5 coronavirus strain, the agency announced Thursday. The decision was made swiftly to…
FDA Committee Recommends Moderna Two-Dose Vaccine For Children
An FDA Committee of independent vaccine experts today endorsed Moderna’s two-dose Covid-19 vaccine for children, a vital hurdle on its path to being given to children. It was approved unanimously…
mRNA Vaccine Creators Are Building More mRNA Infrastructure
Dr. Katalin Karikó and Dr. Drew Weissman, co-creators of the mRNA vaccine technology used in two of the most widely used COVID vaccines, Moderna and Pfizer, are studying the possible…
Pfizer’s Paxlovid Reconsidered For Lower-Risk COVID Patients
Doctors are having second thoughts about using Pfizer Inc’s COVID-19 antiviral pill Paxlovid in lower risk patients. Their reconsideration comes after a US Public Health Agency issued a warning about…
NIH Gives $68M To Pfizer-Partnered AI Startup
A Pfizer-associated Boston startup that uses AI and machine learning to aid drug companies with development and discovery of new drugs was given $68 million from the NIH. PostEra will…
